Trials / Unknown

UnknownNCT00040560

Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer

Status: Unknown
Phase: Phase 1
Study type: Interventional
Enrollment: —

Sponsor: Copharos · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate the safety and imaging ability of 111In-DAC when used with planar and SPECT imaging for the detection of lung cancer and brain cancer consistent with metastatic lung cancer.

Conditions

Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Brain Neoplasms
Metastases, Neoplasm

Interventions

Type	Name	Description
DRUG	111In-DAC
PROCEDURE	Diagnostic

Timeline

First posted: 2002-07-02
Last updated: 2005-06-24

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00040560. Inclusion in this directory is not an endorsement.